Research coauthored by RTI Health Solutions researchers will be presented at AASLD 2022 Liver Meeting.
Predicting treatment choices for unresectable hepatocellular carcinoma (HCC): results from a patient preference study. Li D, Tan A, Hernandez S, Reilly N, Bussberg C, Mansfield C.
